• Follow us
  • EN
    Flag Indonesia ID
    Flag English EN
Untitled design (6)
  • About Us
    • Company Profile
      • PT Bio Farma (Persero)
      • Kimia Farma Tbk (KAEF)
      • Indofarma Tbk (INAF)
      • PT INUKI (Persero)
    • History
    • Management
      • Commisioners
      • Directors
    • Research & Development
    • Our Achievement
      • Awards
      • Certification
    • Report
      • Annual Report
      • Sustainability
  • Product & Services
    • Our Distribution
    • Product & Services
      • Life Sciences
      • Providers of Health Services & Products
      • Trade, Distribution of Medicines & Medical Devices
    • Immunization Services
    • Cervical Cancer Screening Service
    • FAQ
  • Media & Information
    • News
      • All News
      • Global Roles
      • Products & Services
      • CSR
    • Health Articles
    • Health FAQ
    • Our Procurement
  • Corporation
    • Good Corporate Governance
    • Our Commitment
    • CSR
    • LHKPN
      • Lapor
  • Career
    • Recruitment
  • PPID
  • Contact Us
search

Vaksin Pentabio siap masuk pasar Ekspor

Monday, 7 December 2015

(Bandung, 30th December 2014) On 16th December 2014, the 5 in 1 Product of Pentabio Vaccine (Diphtheria, Tetanus, Pertusis, Hepatitis B, Haemophilus influanzae type b) have passed Pre-qualification (PQ) of the World Health Organization hence these products are added to the vaccine portfolio of Bio Farma that are listed to be purchased by the World Health Organization (WHO), UNICEF, PAHO and other countries in the world, in addition to prioritizing the needs of the domestic market. This information was conveyed by Iskandar, President Director of Bio Farma in between the inauguration speech of the Administration Building 2 as well as the laying of the cornerstone of the construction of the production and packaging facility, “with the addition of the Pentabio Vaccine product, the Total of Bio Farma’s vaccine products that are listed at WHO are as many as 13 products” Iskandar said. The World Health Organization (WHO) has the authority to assess the quality, safety and efficacy of the vaccine products from various manufacturers in the world. The WHO pre-qualification is carried out to assess the quality of the vaccine, whether or not it meets the tender specifications, quality standards. An important aspect in the WHO pre-qualification includes management commitment, the implementation of a comprehensive quality management system, as well as the quality of the National Agency of Food and Drug Control (NADFC or Badan POM) in the country. Iskandar added, that they are very grateful and convey their gratitude for the maximum efforts of all employees of Bio Farma as the process of obtaining the WHO PQ is not an easy task. This decision was based on the review of the Product Summary File, evaluation on the consistency of the characteristics in the final product, visitation audits to the production facility and the follow up of the implementation of recommendation made by the WHO reviewer during the evaluation. The following is the list of vaccines that are PQ from Bio Farma since 1997 to the present day.

  For next information, please contact :   N. Nurlaela Head of Corporate Communications Dept. PT Bio Farma (Persero) Telp : 022 203 3755 Fax : 022 204 1306 E-mail : corcom@biofarma.co.id

  • Share to:
Download

Latest News

WhatsApp Image 2024-07-26 at 15.00.55 (1)
Friday, 26 July 2024
Turut Peringati Hari Konservasi Alam Nasional 2024 : Bio Farma Lepasliarkan Owa Jawa dan Surili di Cagar Alam Gunung Tilu, Jabar
JOKOWI INDOVAC
Wednesday, 23 November 2022
IndoVac Can Be Used by the Elderly for the Second Booster of the Covid-19 Vaccine
IDC awards 2022
Friday, 18 November 2022
Bio Farma Wins IDC Future Enterprise Awards 2022 Indonesia
View more

Logo biofarma

Call Center 1500810

Head Office

Jl. Pasteur No. 28, Bandung 40161,
Jawa Barat Indonesia
+62 22-2033755
+62 22 - 2041306
mail@biofarma.co.id

Breeding Facility Bio Farma

Jl. Kolonel Masturi Kav 10. Desa Kertawangi kec. Cisarua
Jawa Barat

Bio Farma Representative Office

Gd. Pakarti centre Lantai 7
Jln. Tanah Abang 3 no.23-27
Jakarta Pusat

Information

  • Good Corporate Governance
  • Our Procurement
  • FAQ
  • Vaccine Production
  • Your Career

 

  • Contact Us
  • E-PPID
  • Announcement
  • Media Release

Quick Links

  • Portal BUMN-Bio
  • Kemenkes RI
Copyright © 2026. All Rights Reserved by Bio Farma

Change Language

EN
  • About Us
    • Company Profile
      • Company Profile
      • PT Bio Farma (Persero)
      • Kimia Farma Tbk (KAEF)
      • Indofarma Tbk (INAF)
      • PT INUKI (Persero)
    • History
    • Management
      • Commisioners
      • Directors
    • Research & Development
    • Our Achievement
      • Awards
      • Certification
    • Report
      • Annual Report
      • Sustainability
  • Product & Services
    • Our Distribution
    • Product & Services
      • Life Sciences
      • Providers of Health Services & Products
      • Trade, Distribution of Medicines & Medical Devices
    • Immunization Services
    • Cervical Cancer Screening Service
    • FAQ
  • Media & Information
    • News
      • All News
      • Global Roles
      • Products & Services
      • CSR
    • Health Articles
    • Health FAQ
    • Our Procurement
  • Corporation
    • Good Corporate Governance
    • Our Commitment
    • CSR
    • LHKPN
      • Lapor
  • Career
    • Career
    • Recruitment
  • PPID
  • Contact Us
  • Follow us
Change Language
  • Flag Indonesia ID
  • Flag English EN